Patent Law Practice Center

U.S. Drug Sales and a Patent Cliff

Drugs.com, a leading online drug resource, just released second quarter 2012 U.S. prescription sales data for the top 100 drugs.

Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top-selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be affected by year’s end.

1. Nexium — $1,380,413,000
2. Abilify — $1,379,149,000
3. Singulair — $1,287,806,000
4. Advair Diskus — $1,124,985,000
5. Crestor — $1,124,702,000
6. Cymbalta — $1,057,821,000
7. Humira — $1,015,639,000
8. Enbrel — $948,119,000
9. Plavix — $934,731,000
10. Remicade — $933,255,000

(more…)